A detailed history of Vident Advisory, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 24,050 shares of INVA stock, worth $427,849. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,050
Previous 31,391 23.39%
Holding current value
$427,849
Previous $515 Million 9.79%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.33 - $20.04 $119,878 - $147,113
-7,341 Reduced 23.39%
24,050 $464 Million
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $452,030 - $514,812
31,391 New
31,391 $515 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.